Efficacy of camrelizumab (SHR-1210) plus apatinib as second-line treatment for advanced squamous NSCLC

Gao, G; Wang, Y; Ren, S; Zhao, J; Chen, G; Chen, J; Gu, K; Guo, R; Pan, Y; Wang, Q; Zhou, C

ANNALS OF ONCOLOGY, 2020; 31 (): S819